News FDA: Update on US Varenicline Supply Publish Date May 6, 2022 Manufacturers can now adequately supply the market with varenicline at or below the acceptable intake limit of 37ng per day.
Drugs in the Pipeline Significant Smoking Cessation Observed With Cytisinicline in Phase 3 Trial Publish Date April 27, 2022 The placebo-controlled ORCA-2 study evaluated the safety and efficacy of cytisinicline as a treatment for smoking cessation in 810 adult smokers.